The Venture Capital Firm Set to Expand Investments in
Innovative Healthcare Companies
NEW
YORK, June 27, 2024 /PRNewswire/ -- Zoi Capital,
a venture capital firm specializing in artificial intelligence (AI)
solutions for healthcare, was founded by Mayo Clinic-trained
cardiologist Dr. Ronald M. Razmi and Brian K. Beeler, former Executive VP and General
Counsel of Horizon Therapeutics. The co-founders and Managing
Directors share more than 50 years of experience in the medical
technology field and have been responsible for more than
$30 billion in exits via public
markets and acquisitions. Announce their fundraising goal of
$200 million for their Health AI Fund
I.
Zoi Capital was conceptualized after a former G7 Nation Head of
State reached out to Dr. Razmi for help in evaluating how AI can
increase access to high-quality healthcare. The conversation
illuminated the need for experts with deep health AI expertise to
drive the selection of the best use cases for funding. In
the United States, the stakes are
especially high because if the U.S. healthcare sector were a
country, its $4.5 trillion size would
rank as the fourth largest in the world, surpassing Japan's entire economy.
"Much of the investment in the emerging health AI sector has
gone into use cases that have a hard time gaining traction," said
Dr. Razmi. "This is due to a myriad of issues such as unproven
economic benefits to the buyers, use cases not being ready for
prime time, and inadequately trained AI models. You now need a new
breed of investors who have clinical and operating experience with
these technologies in healthcare to direct capital to the best
companies" Razmi notes.
Against a backdrop of the recent decline in fundraising by
venture funds and startups, Zoi Capital's founders believe that a
new approach to private market investing is needed. Brian Beeler noted "We believe high returns on
capital will be earned by specialist investors with a deep focus on
one sector. To that end, Zoi has assembled a team of digital health
operators and investors to pursue this opportunity." Zoi leverages
its deep relationships with the leading medical institutions to
secure deal flow and uses a set of proprietary score-cards for
selecting the best companies. The Zoi team utilizes its extensive
past operating experience in supporting their portfolio companies
to formulate the optimal commercialization strategy and scale
up.
For more information, please visit: www.zoicap.com
About Zoi Capital
Zoi Capital is a thematic venture capital firm that specializes
in the growing applications of artificial intelligence in
healthcare.
Led by Brian K. Beeler, a former
life science company executive that has been involved with managing
multiple corporate venture funds and over $7
billion in transactions, and Dr. Ronald M. Razmi, former Cardiologist, McKinsey
consultant, CEO of Acupera, and author of the new book, AI Doctor:
The Rise of Artificial Intelligence in Healthcare, the firm's
competitive advantages include cross-functional expertise in
practicing medicine, operating successful digital health companies,
and investing in medical technologies.
With the help of their proprietary investment platform, AI Doc,
Zoi Capital is able to find and select companies with technologies
that provide immediate benefit to healthcare stakeholders while
solving for the unique friction points that usually derail or delay
adoption. While relationships with top academic medical centers
provide access to unique deal flow, Zoi plays an active role in
improving the product road map, optimizing commercialization
strategy, and facilitating faster exits.
Press Contact:
Michelle Moskowitz
917-597-0863
View original content to download
multimedia:https://www.prnewswire.com/news-releases/zoi-capital-founders-and-industry-veterans-announce-200-million-dollar-fund-targeting-ai-technologies-with-practical-applications-for-healthcare-302184809.html
SOURCE Zoi Capital